Literature DB >> 3293090

The metabolic basis for combination chemotherapy.

L E Damon1, E C Cadman.   

Abstract

Mesh:

Substances:

Year:  1988        PMID: 3293090     DOI: 10.1016/0163-7258(88)90103-9

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


× No keyword cloud information.
  5 in total

1.  Implications and problems in analysing cytotoxic activity of hydroxyurea in combination with a potential inhibitor of ribonucleotide reductase.

Authors:  G Nocentini; A Barzi; P Franchetti
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

2.  Sequence-dependent cytotoxic effects of the combination of a new nitrosourea, fotemustine, with 5-fluorouracil plus folinic acid.

Authors:  J L Fischel; P Formento; M Berlion; J Berille; J Gioanni; J P Bizzari; G Milano
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

3.  Cytotoxicity of ICD-85 NPs on Human Cervical Carcinoma HeLa Cells through Caspase-8 Mediated Pathway.

Authors:  Saeed Moradhaseli; Abbas Zare Mirakabadi; Ali Sarzaeem; Morteza Kamalzadeh; Reza Haji Hosseini
Journal:  Iran J Pharm Res       Date:  2013       Impact factor: 1.696

Review 4.  Cutting down the time to identify challenging tumor therapeutic targets and drug combinations using synthetic lethal approaches.

Authors:  John S Lazo
Journal:  F1000Res       Date:  2018-03-12

5.  Long Non-Coding RNA (LncRNA) UFC1/miR-34a Contributes to Proliferation and Migration in Breast Cancer.

Authors:  Ruilian Xie; Maoyuan Wang; Wenting Zhou; Dan Wang; Yan Yuan; Huaqiu Shi; Longqiu Wu
Journal:  Med Sci Monit       Date:  2019-09-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.